Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set.

S B Cantor1, T G Ganiats

  • 1University of Texas M.D. Anderson Cancer Center, Department of Medical Specialties, Houston 77030-4095, USA.

Journal of Clinical Epidemiology
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.

British journal of cancer·2015
Same author

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same author

View point: health promotion program cost effectiveness - a response to murphy et Al.

American journal of health promotion : AJHP·2012
Same author

Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.

Oncogene·2010
Same author

BACH1 is a DNA repair protein supporting BRCA1 damage response.

Oncogene·2006
Same author

A pilot study for a screening trial of cervical fluorescence spectroscopy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
Same journal

What's the Meta Now? More Updates on the Problems with Systematic Reviews.

Journal of clinical epidemiology·2026
Same journal

A scoping review of guidance on sharing trial results with patients and the public finds inconsistent recommendations and limited methodological development.

Journal of clinical epidemiology·2026
Same journal

Patterns of social determinants of health and their associations with health indicators: A latent class analysis.

Journal of clinical epidemiology·2026
See all related articles

The choice of comparison strategies significantly impacts cost-effectiveness analysis results. Carefully selecting alternatives is crucial for accurate healthcare technology assessments and policy decisions.

Area of Science:

  • Health economics
  • Medical decision making
  • Clinical strategy evaluation

Background:

  • Incremental cost-effectiveness analysis (ICER) is vital for technology adoption decisions.
  • The selection of comparator strategies can influence ICER outcomes.
  • Previous studies provide a foundation for cost and effectiveness assumptions.

Purpose of the Study:

  • To demonstrate how the choice of alternatives affects cost-effectiveness analysis.
  • To analyze the incremental cost-effectiveness of estriol screening for Down syndrome.

Main Methods:

  • Utilized a cost-effectiveness model based on published data.
  • Compared four clinical strategies, including a 'do nothing' approach.
  • Evaluated incremental cost-effectiveness ratios (ICERs) under different strategy sets.

Related Experiment Videos

Main Results:

  • Including a 'do nothing' strategy led to extended dominance, rendering two strategies non-cost-effective.
  • Excluding the 'do nothing' strategy allowed all remaining three strategies to be potentially cost-effective.
  • The starting point for analysis critically influences the interpretation of cost-effectiveness.

Conclusions:

  • The incremental cost-effectiveness of clinical strategies is highly sensitive to the comparator set.
  • Policy decisions based on ICERs require careful consideration of the analytical framework.
  • Methodological choices in cost-effectiveness analysis have significant implications for healthcare policy.